Unmasking pustular psoriasis subsequent to COVID-19 | [Journal of Pakistan Association of Dermatologists • 2021]

Author(s):

1. Ronak Miladi: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

2. Alireza Janbakhsh: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

3. Arefeh Babazadeh: Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran.

4. Zeinab Aryanian: Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.

5. Soheil Ebrahimpour: Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, I.R. Iran.

6. Zeinab Mohseni Afshar: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences,Kermanshah,Iran

Abstract:

Various cutaneous manifestations have recently appeared within context of 2019 novel coronavirus diseases (COVID-19). Currently, outbreaks of psoriasis were reported during COVID-19. We reported a case of a 32-year-old woman with COVID-19 who presented with pustular psoriasis. She was treated with oral prednisolone, hydroxyzine and topical clobetasol. The two-week follow-up revealed that her lesions were desquamating and that she was in a favorable situation. The current report will highlight specific skin manifestations of COVID-19, allowing clinicians to further confirm our suspicions.

Page(s): 526-529

DOI: DOI not available

Published: Journal: Journal of Pakistan Association of Dermatologists, Volume: 31, Issue: 3, Year: 2021

Keywords:

COVID19 , Azithromycin , Hydroxychloroquine , Pustular psoriasis

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views